日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancer

结构多样性的不同发展轨迹会影响高级别浆液性卵巢癌患者的生存率

Ewing, Ailith; Meynert, Alison; Silk, Ryan; Aitken, Stuart; Bendixsen, Devin P; Churchman, Michael; Brown, Stuart L; Hamdan, Alhafidz; Mattocks, Joanne; Grimes, Graeme R; Ballinger, Tracy; Hollis, Robert L; Simon Herrington, C; Thomson, John P; Sherwood, Kitty; Parry, Thomas; Esiri-Bloom, Edward; Bartos, Clare; Croy, Ian; Ferguson, Michelle; Lennie, Mairi; McGoldrick, Trevor; McPhail, Neil; Siddiqui, Nadeem; Glasspool, Rosalind; Mackean, Melanie; Nussey, Fiona; McDade, Brian; Ennis, Darren; McMahon, Lynn; Matakidou, Athena; Dougherty, Brian; March, Ruth; Carl Barrett, J; McNeish, Iain A; Biankin, Andrew V; Roxburgh, Patricia; Gourley, Charlie; Semple, Colin A

Comprehensive comparison of enzymatic and bisulfite DNA methylation analysis in clinically relevant samples.

对临床相关样本中酶法和亚硫酸氢盐法DNA甲基化分析进行全面比较。

Nuttall Barrett, Karl Daniel L, Burke Kathleen, Callahan Megan, Mendler Kerrin, Cingolani Pablo, Criscione Steven, Naumenko Serhiy, Bibikova Elena, Munugalavadla Veerendra, Byrd John C, Furman Richard R, Brown Jennifer R, Mortlock Andrew, Dougherty Brian A, Carl Barrett J, Scaltriti Maurizio, Hadfield James

Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

非小细胞肺癌获得性免疫治疗耐药的临床和分子特征

Danish Memon,Adam J Schoenfeld,Darwin Ye,George Fromm,Hira Rizvi,Xiang Zhang,Mohamed Reda Keddar,Divij Mathew,Kyung Jin Yoo,Jingya Qiu,Jayon Lihm,Jayalaksmi Miriyala,Jennifer L Sauter,Jia Luo,Andrew Chow,Umesh K Bhanot,Caroline McCarthy,Chad M Vanderbilt,Cailian Liu,Mohsen Abu-Akeel,Andrew J Plodkowski,Nicholas McGranahan,Marta Łuksza,Benjamin D Greenbaum,Taha Merghoub,Ikbel Achour,J Carl Barrett,Ross Stewart,Pedro Beltrao,Taylor H Schreiber,Andy J Minn,Martin L Miller,Matthew D Hellmann

Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

非小细胞肺癌获得性免疫治疗耐药的临床和分子特征

Danish Memon ,Adam J Schoenfeld ,Darwin Ye ,George Fromm ,Hira Rizvi ,Xiang Zhang ,Mohamed Reda Keddar ,Divij Mathew ,Kyung Jin Yoo ,Jingya Qiu ,Jayon Lihm ,Jayalaksmi Miriyala ,Jennifer L Sauter ,Jia Luo ,Andrew Chow ,Umesh K Bhanot ,Caroline McCarthy ,Chad M Vanderbilt ,Cailian Liu ,Mohsen Abu-Akeel ,Andrew J Plodkowski ,Nicholas McGranahan ,Marta Łuksza ,Benjamin D Greenbaum ,Taha Merghoub ,Ikbel Achour ,J Carl Barrett ,Ross Stewart ,Pedro Beltrao ,Taylor H Schreiber ,Andy J Minn ,Martin L Miller ,Matthew D Hellmann

Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study

广泛期小细胞肺癌的分子分类和免疫治疗结果的生物标志物:CASPIAN 3 期研究分析

Mingchao Xie, Miljenka Vuko, Jaime Rodriguez-Canales, Johannes Zimmermann, Markus Schick, Cathy O'Brien, Luis Paz-Ares, Jonathan W Goldman, Marina Chiara Garassino, Carl M Gay, John V Heymach, Haiyi Jiang, J Carl Barrett, Ross A Stewart, Zhongwu Lai, Lauren A Byers, Charles M Rudin, Yashaswi Shresth

The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment

ATR抑制剂ceralasertib通过调节肿瘤微环境增强癌症检查点免疫疗法的疗效。

Elizabeth L Hardaker # ,Emilio Sanseviero # ,Ankur Karmokar # ,Devon Taylor # ,Marta Milo ,Chrysis Michaloglou ,Adina Hughes ,Mimi Mai ,Matthew King ,Anisha Solanki ,Lukasz Magiera ,Ricardo Miragaia ,Gozde Kar ,Nathan Standifer ,Michael Surace ,Shaan Gill ,Alison Peter ,Sara Talbot ,Sehmus Tohumeken ,Henderson Fryer ,Ali Mostafa ,Kathy Mulgrew ,Carolyn Lam ,Scott Hoffmann ,Daniel Sutton ,Larissa Carnevalli ,Fernando J Calero-Nieto ,Gemma N Jones ,Andrew J Pierce ,Zena Wilson ,David Campbell ,Lynet Nyoni ,Carla P Martins ,Tamara Baker ,Gilberto Serrano de Almeida ,Zainab Ramlaoui ,Abdel Bidar ,Benjamin Phillips ,Joseph Boland ,Sonia Iyer ,J Carl Barrett ,Arsene-Bienvenu Loembé ,Serge Y Fuchs ,Umamaheswar Duvvuri ,Pei-Jen Lou ,Melonie A Nance ,Carlos Alberto Gomez Roca ,Elaine Cadogan ,Susan E Critichlow ,Steven Fawell ,Mark Cobbold ,Emma Dean ,Viia Valge-Archer ,Alan Lau ,Dmitry I Gabrilovich ,Simon T Barry

The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment

ATR抑制剂ceralasertib通过调节肿瘤微环境增强癌症检查点免疫疗法的疗效。

Elizabeth L Hardaker #,Emilio Sanseviero #,Ankur Karmokar #,Devon Taylor #,Marta Milo,Chrysis Michaloglou,Adina Hughes,Mimi Mai,Matthew King,Anisha Solanki,Lukasz Magiera,Ricardo Miragaia,Gozde Kar,Nathan Standifer,Michael Surace,Shaan Gill,Alison Peter,Sara Talbot,Sehmus Tohumeken,Henderson Fryer,Ali Mostafa,Kathy Mulgrew,Carolyn Lam,Scott Hoffmann,Daniel Sutton,Larissa Carnevalli,Fernando J Calero-Nieto,Gemma N Jones,Andrew J Pierce,Zena Wilson,David Campbell,Lynet Nyoni,Carla P Martins,Tamara Baker,Gilberto Serrano de Almeida,Zainab Ramlaoui,Abdel Bidar,Benjamin Phillips,Joseph Boland,Sonia Iyer,J Carl Barrett,Arsene-Bienvenu Loembé,Serge Y Fuchs,Umamaheswar Duvvuri,Pei-Jen Lou,Melonie A Nance,Carlos Alberto Gomez Roca,Elaine Cadogan,Susan E Critichlow,Steven Fawell,Mark Cobbold,Emma Dean,Viia Valge-Archer,Alan Lau,Dmitry I Gabrilovich,Simon T Barry

Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus encoding IL-12

编码 IL-12 的 AZD4820 溶瘤痘苗病毒介导抗肿瘤活性

Cheyne Kurokawa, Sonia Agrawal, Abhisek Mitra, Elena Galvani, Shannon Burke, Ankita Varshine, Raymond Rothstein, Kevin Schifferli, Noel R Monks, Johann Foloppe, Nathalie Silvestre, Eric Quemeneur, Christelle Demeusoit, Patricia Kleinpeter, Puja Sapra, Carl Barrett, Scott A Hammond, Elizabeth J Kelly

Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition

伴随的 KRAS 突变会降低非小细胞肺癌细胞对 KRAS G12C 抑制的敏感性

Tereza Vaclova, Atanu Chakraborty, James Sherwood, Sarah Ross, Danielle Carroll, J Carl Barrett, Julian Downward, Elza C de Bruin

Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers

亚克隆 EGFR T790M 突变对晚期 EGFR 突变型非小细胞肺癌的临床影响

Tereza Vaclova, Ursula Grazini, Lewis Ward, Daniel O'Neill, Aleksandra Markovets, Xiangning Huang, Juliann Chmielecki, Ryan Hartmaier, Kenneth S Thress, Paul D Smith, J Carl Barrett, Julian Downward, Elza C de Bruin